A temperature-driven DNA discrimination strategy to distinguish E. coli DNA and phage 5hmC-modified DNA
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Yue Kang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China. Hauptthemen laut MEDLINE: Escherichia coli, DNA, Viral, DNA, Bacterial, Bacteriophage T4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
The arms race between phages and bacteria is dynamic and ongoing, with both continuously acquiring new strategies to outcompete each other during co-evolution. Here, we report bacteriophage T4 exonuclease DexA and an uncharacterized Escherichia coli exonuclease as a rare pair of attack and defense duo arising from the same mechanism. DexA, highly conserved among phages, has two well-characterized biological roles: host DNA scavenging and intron homing. Unmodified DNA is the substrate during host DNA scavenging, whereas cleavage of 5hmC (5-hydroxymethylcytosine)-modified phage DNA is required for intron homing. We reveal a temperature-driven quaternary fold switch between DexA dimer and tetramer that facilitates cleavage of distinct DNA forms, namely 5hmC-modified phage DNA and unmodified host DNA. As a countermeasure, bacteria produce DexA variants for defense against phage that only targets 5hmC-modified DNA. Thus, both phages and bacteria compete using HmC-Recognizing EXonuclease strategies (designated as HREX).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China.
- Key Laboratory of Surgical Critical Care and Life Support, Biobank, Centre for Biobank and Advanced Medical Research of Shaanxi Province, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China.
- Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology…
- State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
- Department of Biochemistry and Molecular Biology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, 430072, China.
- BioCrystallisation Lab, Chemical Engineering Department, Loughborough University, Loughborough LE11 3TU, United Kingdom.
ORCID-Profile: Shuai Yuan, Bing Liu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Kang, Y., Liu, Y., Zhou, H., Ma, B., Chen, H., Zhang, K., Wang, Y., Fan, C., Yang, H., Xu, Y., Matthews, S., Yuan, S., Li, Y., & Liu, B. (2025). A temperature-driven DNA discrimination strategy to distinguish E. coli DNA and phage 5hmC-modified DNA. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf501
Vancouver
Kang Y, Liu Y, Zhou H, Ma B, Chen H, Zhang K, et al. A temperature-driven DNA discrimination strategy to distinguish E. coli DNA and phage 5hmC-modified DNA. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf501
BibTeX
@article{Kang2025,
author = {Kang, Yue and Liu, Yahui and Zhou, Haolong and Ma, Biyun and Chen, Huan and Zhang, Kaining and Wang, Yawen and Fan, Chengpeng and Yang, Huaiyu and Xu, Yingqi and Matthews, Steve and Yuan, Shuai and Li, Yan and Liu, Bing},
title = {A temperature-driven DNA discrimination strategy to distinguish E. coli DNA and phage 5hmC-modified DNA},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf501}
}
EUVIMED